ArticleJournal of Alzheimer's disease : JAD2026
The social value of lecanemab for patients with early Alzheimer's disease in Japan.
Ataru Igarashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ArticleJournal of Alzheimer's disease : JAD2026
Ataru Igarashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.